Hear from Dr. Eric Pearlman, Associate Vice President at Eli Lilly, as we dive into their findings from the OVERCOME study. This study aims to further understand the stigma experienced by people living with migraine, identify barriers to the appropriate treatment, and assess how novel treatment options may influence delivery of migraine care and outcomes.
